Advertisement

Topics

INSYS Therapeutics, Inc. Company Profile

07:13 EDT 20th September 2017 | BioPortfolio

INSYS Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative products that address chemotherapy-induced nausea and vomiting (CINV), pain management and other central nervous system disorders. We develop new formulations and delivery methods for existing drugs in order to achieve enhanced efficacy, faster onset of action, reduced side effects, convenient delivery and increased patient compliance. Our drug development programs are based on existing compounds with known or proven safety, efficacy and commercialization histories. We are focused on leveraging our expertise in the expanding synthetic cannabinoid derivatives and specialized opioid markets to build a portfolio of proprietary products that address the limitations of existing therapies.


News Articles [1578 Associated News Articles listed on BioPortfolio]

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY

NEW YORK, NY / ACCESSWIRE / May 5, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against INSYS Therapeutics, Inc. ("Insys" or the "Company") (NYSE: INSY) and certain of ...

Anthem files lawsuit against Insys Therapeutics

(Reuters) - Health insurer Anthem Inc filed a lawsuit against Insys Therapeutics Inc  on Wednesday, alleging the drugmaker fraudulently obtained reimbursements for its opioid painkiller Subsys. ...

Arizona sues Chandler-based opioid maker Insys for fraud

Arizona's attorney general is suing the Chandler-based maker of a potent opioid drug, alleging that Insys Therapeutics engaged in fraud to boost the sales of a drug designed for cancer patients. T...

The Klein Law Firm Reminds Investors of the Filing of a Class Action on Behalf of INSYS Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 16, 2017

NEW YORK, NY / ACCESSWIRE / May 15, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of INSYS Therapeutics, Inc. (NASDAQ: INSY) who purchas...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc.

NEW YORK, NY / ACCESSWIRE / May 8, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of INSYS Therapeut...

Ex-Insys employee pleads guilty in U.S. to opioid kickback scheme

(Reuters) - A former Insys Therapeutics Inc sales representative pleaded guilty on Tuesday to having participated in a scheme to pay kickbacks to medical practitioners to prescribe a drug containing t...

AL Doctor Tied to Insys Gets 20 Years for Illegal Prescriptions

An Alabama doctor was sentenced on Thursday to 20 years in prison after being convicted with a colleague of prescribing painkillers through two clinics for no legitimate purpose, in a case tied to the...

Ex-Insys CEO's wife pleads guilty in U.S. to opioid kickback scheme

(Reuters) - A former Insys Therapeutics Inc sales representative who is married to its former chief executive pleaded guilty on Tuesday to engaging in a scheme to pay kickbacks to medical practitioner...

Clinical Trials [117 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Expanded Use of Cannabidiol Oral Solution

To allow subjects who have completed Insys 030 extension study to continue to take Cannabidiol oral solution.

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1144 Associated Companies listed on BioPortfolio]

INSYS Therapeutics, Inc.

INSYS Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative products that address chemotherapy-induced nausea and vomiting (CINV), pain management and ...

INSYS Therapeutics/NeoPharm

INSYS Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative products that address chemotherapy-induced nausea and vomiting (CINV),...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "INSYS Therapeutics, Inc." on BioPortfolio

We have published hundreds of INSYS Therapeutics, Inc. news stories on BioPortfolio along with dozens of INSYS Therapeutics, Inc. Clinical Trials and PubMed Articles about INSYS Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of INSYS Therapeutics, Inc. Companies in our database. You can also find out about relevant INSYS Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record